SCHEMBL15280424

SCHEMBL15280424

COc1ccc(Cc2ccco2)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.61
PKM P14618 1/20 0.55
ALDH1A1 P00352 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 4/20 0.52
TSHR P16473 3/20 0.52
HTT P42858 1/20 0.52
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 2/20 0.49
HSD17B10 Q99714 1/20 0.49
USP2 O75604 2/20 0.49
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 2/20 0.49
HIF1A Q16665 2/20 0.49
PDE10A Q9Y233 2/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31717885 0.86 CALM1 (0.55) ALDH1A1SMN1; SMN2LMNATSHRHTT
SCHEMBL29207888 0.81 MEN1 (0.71) PKMALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL29207946 0.79 MEN1 (0.64) PKMALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL2095593 0.78 CA2 (1.00) CA2ALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL28091649 0.77 LTA4H (0.55) ALDH1A1SMN1; SMN2LMNATSHRHTT
SCHEMBL28164756 0.74 CA2 (0.91) CA2ALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL29449205 0.74 CA2 (0.91) CA2ALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL20871233 0.73 CA2 (0.61) CA2ALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL83495 0.73 CA2 (0.80) CA2ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL21401837 0.72 CHRM2 (0.49) ALDH1A1LMNATSHRHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266490-B2 Radioprotector compounds GEORGETOWN UNIVERSITY (US) 2019-04-23 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
WO-2013138600-A1 RADIOPROTECTOR COMPOUNDS ROSEN ELIOT M (US) 2013-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266490-B2 Radioprotector compounds DDB1, CASP3, BAD CA2 4178/4885PKM 1861/4885ALDH1A1 1017/4885
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS DDB1, CASP3, BAD CA2 4178/4885PKM 1861/4885ALDH1A1 1017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.